Cencora Gross Margin 2012-2025 | COR
Current and historical gross margin for Cencora (COR) over the last 10 years. The current gross profit margin for Cencora as of September 30, 2025 is %.
| Cencora Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $321.33B | $11.48B | 3.57% |
| 2025-06-30 | $316.66B | $11.02B | 3.48% |
| 2025-03-31 | $310.23B | $10.52B | 3.39% |
| 2024-12-31 | $303.19B | $10.00B | 3.30% |
| 2024-09-30 | $293.96B | $9.91B | 3.37% |
| 2024-06-30 | $283.83B | $9.67B | 3.41% |
| 2024-03-31 | $276.54B | $9.53B | 3.44% |
| 2023-12-31 | $271.58B | $9.28B | 3.42% |
| 2023-09-30 | $262.17B | $8.96B | 3.42% |
| 2023-06-30 | $254.43B | $8.69B | 3.42% |
| 2023-03-31 | $247.54B | $8.44B | 3.41% |
| 2022-12-31 | $241.81B | $8.38B | 3.47% |
| 2022-09-30 | $238.59B | $8.30B | 3.48% |
| 2022-06-30 | $236.33B | $8.38B | 3.55% |
| 2022-03-31 | $229.67B | $8.25B | 3.59% |
| 2021-12-31 | $221.10B | $7.55B | 3.41% |
| 2021-09-30 | $213.99B | $6.94B | 3.24% |
| 2021-06-30 | $204.32B | $6.22B | 3.04% |
| 2021-03-31 | $196.28B | $5.56B | 2.83% |
| 2020-12-31 | $194.55B | $5.41B | 2.78% |
| 2020-09-30 | $189.90B | $5.19B | 2.73% |
| 2020-06-30 | $186.29B | $5.03B | 2.70% |
| 2020-03-31 | $186.16B | $5.04B | 2.70% |
| 2019-12-31 | $182.06B | $5.07B | 2.79% |
| 2019-09-30 | $179.59B | $5.14B | 2.86% |
| 2019-06-30 | $177.25B | $4.99B | 2.81% |
| 2019-03-31 | $175.15B | $4.97B | 2.84% |
| 2018-12-31 | $172.87B | $4.80B | 2.78% |
| 2018-09-30 | $167.94B | $4.61B | 2.75% |
| 2018-06-30 | $163.76B | $4.75B | 2.90% |
| 2018-03-31 | $159.33B | $4.62B | 2.90% |
| 2017-12-31 | $155.44B | $4.62B | 2.97% |
| 2017-09-30 | $153.14B | $4.55B | 2.97% |
| 2017-06-30 | $151.58B | $4.50B | 2.97% |
| 2017-03-31 | $149.76B | $4.53B | 3.02% |
| 2016-12-31 | $148.31B | $4.35B | 2.93% |
| 2016-09-30 | $146.85B | $4.27B | 2.91% |
| 2016-06-30 | $144.76B | $4.12B | 2.85% |
| 2016-03-31 | $142.11B | $3.91B | 2.75% |
| 2015-12-31 | $139.08B | $3.74B | 2.69% |
| 2015-09-30 | $135.96B | $3.53B | 2.60% |
| 2015-06-30 | $132.08B | $3.43B | 2.60% |
| 2015-03-31 | $128.20B | $3.23B | 2.52% |
| 2014-12-31 | $123.98B | $3.05B | 2.46% |
| 2014-09-30 | $119.57B | $2.98B | 2.49% |
| 2014-06-30 | $112.45B | $2.68B | 2.38% |
| 2014-03-31 | $104.01B | $2.55B | 2.45% |
| 2013-12-31 | $96.08B | $2.54B | 2.64% |
| 2013-09-30 | $87.96B | $2.51B | 2.85% |
| 2013-06-30 | $82.23B | $2.64B | 3.21% |
| 2013-03-31 | $79.65B | $2.75B | 3.45% |
| 2012-12-31 | $78.83B | $2.71B | 3.44% |
| 2012-09-30 | $78.08B | $2.64B | 3.37% |
| 2012-06-30 | $78.23B | $2.47B | 3.16% |
| 2012-03-31 | $79.07B | $2.46B | 3.11% |
| 2011-12-31 | $79.12B | $2.46B | 3.11% |
| 2011-09-30 | $78.70B | $2.46B | 3.12% |
| 2011-06-30 | $79.35B | $2.48B | 3.13% |
| 2011-03-31 | $78.79B | $2.42B | 3.07% |
| 2010-12-31 | $78.33B | $2.34B | 2.99% |
| 2010-09-30 | $77.78B | $2.32B | 2.99% |
| 2010-06-30 | $76.96B | $2.30B | 2.99% |
| 2010-03-31 | $75.75B | $2.23B | 2.95% |
| 2009-12-31 | $73.76B | $2.17B | 2.95% |
| 2009-09-30 | $71.76B | $2.10B | 2.93% |
| 2009-06-30 | $70.20B | $2.09B | 2.97% |
| 2009-03-31 | $69.81B | $2.07B | 2.96% |
| 2008-12-31 | $70.25B | $2.05B | 2.92% |
| 2008-09-30 | $70.19B | $2.05B | 2.91% |
| 2008-06-30 | $69.12B | $1.97B | 2.84% |
| 2008-03-31 | $67.47B | $2.04B | 3.02% |
| 2007-12-31 | $66.23B | $2.11B | 3.18% |
| 2007-09-30 | $65.67B | $2.22B | 3.38% |
| 2007-06-30 | $64.83B | $2.25B | 3.47% |
| 2007-03-31 | $64.18B | $2.23B | 3.48% |
| 2006-12-31 | $62.88B | $2.19B | 3.48% |
| 2006-09-30 | $60.81B | $2.12B | 3.49% |
| 2006-06-30 | $59.48B | $2.17B | 3.65% |
| 2006-03-31 | $57.62B | $2.11B | 3.67% |
| 2005-12-31 | $55.59B | $2.05B | 3.69% |
| 2005-09-30 | $54.58B | $1.98B | 3.63% |
| 2005-06-30 | $54.03B | $1.95B | 3.61% |
| 2005-03-31 | $53.25B | $2.02B | 3.79% |
| 2004-12-31 | $53.42B | $2.10B | 3.92% |
| 2004-09-30 | $53.12B | $2.17B | 4.08% |
| 2004-06-30 | $52.32B | $2.24B | 4.28% |
| 2004-03-31 | $51.68B | $2.23B | 4.31% |
| 2003-12-31 | $50.49B | $2.23B | 4.41% |
| 2003-09-30 | $49.59B | $2.23B | 4.49% |
| 2003-06-30 | $48.62B | $2.19B | 4.51% |
| 2003-03-31 | $47.82B | $2.14B | 4.48% |
| 2002-12-31 | $46.60B | $2.07B | 4.45% |
| 2002-09-30 | $45.24B | $2.02B | 4.47% |
| 2002-06-30 | $39.52B | $1.76B | 4.46% |
| 2002-03-31 | $31.42B | $1.40B | 4.45% |
| 2001-12-31 | $23.95B | $1.03B | 4.32% |
| 2001-09-30 | $16.19B | $0.70B | 4.32% |
| 2001-06-30 | $13.34B | $0.57B | 4.29% |
| 2001-03-31 | $12.75B | $0.56B | 4.37% |
| 2000-12-31 | $12.11B | $0.54B | 4.43% |
| 2000-09-30 | $11.65B | $0.52B | 4.47% |
| 2000-06-30 | $11.19B | $-0.08B | -0.75% |
| 2000-03-31 | $10.52B | $-0.11B | -1.05% |
| 1999-12-31 | $9.86B | $-0.13B | -1.32% |
| 1999-09-30 | $9.19B | $-0.15B | -1.61% |
| 1999-06-30 | $8.86B | $0.54B | 6.14% |
| 1999-03-31 | $8.69B | $0.54B | 6.20% |
| 1998-12-31 | $8.71B | $0.54B | 6.21% |
| 1998-09-30 | $8.79B | $0.55B | 6.20% |
| 1998-06-30 | $8.76B | $0.43B | 4.86% |
| 1998-03-31 | $8.73B | $0.43B | 4.89% |
| 1997-12-31 | $8.32B | $0.41B | 4.89% |
| 1997-09-30 | $7.82B | $0.39B | 4.95% |
| 1997-06-30 | $7.08B | $0.35B | 4.98% |
| 1997-03-31 | $6.44B | $0.33B | 5.19% |
| 1996-12-31 | $6.02B | $0.32B | 5.30% |
| 1996-09-30 | $5.55B | $0.30B | 5.46% |
| 1996-06-30 | $5.27B | $0.39B | 7.33% |
| 1996-03-31 | $5.04B | $0.37B | 7.37% |
| 1995-12-31 | $3.68B | $-0.85B | -23.02% |
| 1995-09-30 | $3.55B | $-0.85B | -24.03% |
| 1995-06-30 | $3.43B | $0.07B | 2.13% |
| 1995-03-31 | $3.32B | $1.09B | 32.71% |
| 1994-12-31 | $4.39B | $3.29B | 75.06% |
| 1994-09-30 | $4.28B | $4.28B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $69.838B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.220B | 28.17 |
| HCA Healthcare (HCA) | United States | $114.565B | 17.76 |
| CVS Health (CVS) | United States | $96.096B | 11.22 |
| Elevance Health (ELV) | United States | $71.870B | 10.79 |
| Natera (NTRA) | United States | $29.276B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.585B | 17.98 |
| DiDi Global (DIDIY) | China | $22.403B | 20.70 |
| Viatris (VTRS) | United States | $18.371B | 6.85 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.777B | 0.00 |
| Solventum (SOLV) | United States | $13.956B | 13.55 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.564B | 29.15 |
| CochLear (CHEOY) | Australia | $11.879B | 0.00 |
| Revvity (RVTY) | United States | $11.876B | 20.66 |
| ICON (ICLR) | Ireland | $11.673B | 11.58 |
| Charles River Laboratories (CRL) | United States | $8.920B | 17.18 |
| Sonic Healthcare (SKHHY) | Australia | $7.755B | 0.00 |
| Avantor (AVTR) | United States | $7.609B | 11.62 |
| BrightSpring Health Services (BTSG) | United States | $7.095B | 42.30 |
| HealthEquity (HQY) | United States | $6.694B | 25.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.255B | 0.00 |
| PACS (PACS) | United States | $6.182B | 37.59 |
| Bausch + Lomb (BLCO) | Canada | $6.076B | 39.88 |
| Sotera Health (SHC) | United States | $4.960B | 23.92 |
| Alignment Healthcare (ALHC) | United States | $4.128B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.058B | 19.09 |
| GeneDx Holdings (WGS) | United States | $2.740B | 48.11 |
| Establishment Labs Holdings (ESTA) | United States | $2.109B | 0.00 |
| Organon (OGN) | United States | $2.030B | 2.14 |
| Progyny (PGNY) | United States | $1.855B | 36.47 |
| Pediatrix Medical (MD) | United States | $1.811B | 10.81 |
| Surgery Partners (SGRY) | United States | $1.802B | 23.22 |
| Ardent Health (ARDT) | United States | $1.286B | 4.20 |
| InnovAge Holding (INNV) | United States | $1.136B | 167.40 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| Teladoc Health (TDOC) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.791B | 12.94 |
| Nutex Health (NUTX) | United States | $0.717B | 5.48 |
| Omada Health (OMDA) | United States | $0.656B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.646B | 0.00 |
| Embecta (EMBC) | United States | $0.609B | 3.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.604B | 0.00 |
| Enhabit (EHAB) | United States | $0.566B | 25.43 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.485B | 8.92 |
| CryoPort (CYRX) | United States | $0.436B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.393B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| So-Young (SY) | China | $0.374B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| Shoulder Innovations (SI) | United States | $0.272B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Agilon Health (AGL) | United States | $0.187B | 0.00 |
| Beauty Health (SKIN) | United States | $0.148B | 0.00 |
| LifeMD (LFMD) | United States | $0.147B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.113B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.07 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |